Table 1.

Percent injected dose of Al¹⁸F-NODA-butyric acid and ¹³¹I-OIH in blood, urine and selected organs at 10 and 60 minutes in normal rats^a (Group A) and in rats^a with renal pedicle ligatation (Group B).

	Blood		Kidney		Urine			Liver		Bowelb
	18F	131I-OIH	18F	131I-OIH	18F	131I-OIH	% 18F / 131I-OIH	18F	131I-OIH	18F	131I-OIH
Group A
10 min	8.5 ± 0.8c	5.1 ± 0.5	4.6 ± 0.8d	5.3 ± 1.2	29.3 ± 3.7c	50.8 ± 5.2	58 ± 4	2.3 ± 0.4c	3.3 ± 0.2	1.2 ± 0.3d	1.7 ± 0.5
60 min	1.6 ± 0.3c	0.8 ± 0.1	1.9 ± 0.4c	0.7 ± 0.4	78.6 ± 4.8c	85.4 ± 3.1	92 ± 3	0.7 ± 0.1e	0.6 ± 0.2	0.7 ± 0.1c	1.8 ± 0.3
Group B
60 min	13.5 ± 0.7c	15.1 ± 0.9	0.4 ± 0.1e	0.5 ± 0.2	-	-	-	4.0 ± 0.2c	7.1 ± 0.6	3.2 ± 0.6c	7.6 ± 1.1

Data are presented as mean ± SD.

^a(10 min n=7, 60 min n=5, lig.ped. 60 min n=5).

^bBowel includes intestines and stomach.

^cP < 0.001,

^dP < 0.05 and

^eP > 0.07, comparison of biodistribution between Al¹⁸F-NODA-butyric acid and ¹³¹I-OIH.